Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atossa Therapeutics Inc
(NQ:
ATOS
)
0.7951
-0.0149 (-1.84%)
Streaming Delayed Price
Updated: 11:41 AM EST, Jan 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
193,510
Open
0.8200
Bid (Size)
0.7950 (1)
Ask (Size)
0.8027 (5)
Prev. Close
0.8100
Today's Range
0.7950 - 0.8399
52wk Range
0.5000 - 1.620
Shares Outstanding
126,624,110
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
During Monday's session, 49 companies made new 52-week lows.
Via
Benzinga
Performance
YTD
+35.64%
+35.64%
1 Month
+54.06%
+54.06%
3 Month
-21.28%
-21.28%
6 Month
-14.69%
-14.69%
1 Year
-36.90%
-36.90%
More News
Read More
Recap: Atossa Therapeutics Q2 Earnings
August 08, 2022
Via
Benzinga
Why Is NuZee Down By Over 21%: Here Are 38 Stocks Moving Premarket
August 08, 2022
Via
Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
June 08, 2022
Via
Benzinga
61 Biggest Movers From Yesterday
April 28, 2022
Via
Benzinga
Analyzing Atossa Therapeutics's Unusual Options Activity
August 04, 2021
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 20, 2021
Via
Benzinga
ATOS Stock Holders Should Mark Their Calendars for Oct. 7
September 10, 2021
Via
InvestorPlace
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Via
Benzinga
Exposures
Product Safety
Atossa To Conduct Endoxifen Mid-Stage Study In Sweden
September 02, 2021
Via
Benzinga
Atossa Therapeutics Stock Lost Its Covid Mojo, and Its Pipeline Fails To Impress
August 31, 2021
Via
InvestorPlace
Atossa Therapeutics Has a Steep Climb Ahead of It
August 31, 2021
Via
InvestorPlace
Exposures
COVID-19
As its Meme Status Has Come and Gone, Skip Out on Atossa Therapeutics Stock
August 30, 2021
Via
InvestorPlace
Exposures
COVID-19
Atossa Therapeutics May Look Tempting, but There’s No Reason to Get in Now
August 30, 2021
Via
InvestorPlace
With Zero Revenue, I Can’t Get Excited About Atossa
August 17, 2021
Via
InvestorPlace
Exposures
COVID-19
88 Biggest Movers From Yesterday
August 05, 2021
Via
Benzinga
The Bear Case for Atossa Therapeutics Makes More Sense at This Time
August 04, 2021
Via
InvestorPlace
Most Active Equity Options For Midday - Wednesday, Aug. 4
August 04, 2021
Via
Talk Markets
Investors Should Avoid High-Risk Atossa Therapeutics
August 02, 2021
Via
InvestorPlace
The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs
July 31, 2021
Via
Talk Markets
63 Biggest Movers From Friday
August 02, 2021
Via
Benzinga
Exposures
Product Safety
ATOS Stock: The Big News That Has Atossa Therapeutics Plunging 20% Today
July 30, 2021
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.